Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Testosterone is important for women's health, but more research is needed to guide its use.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Estrogen helps improve skin aging and healing, especially in post-menopausal women.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Isolated long hairs at the original hairline can help diagnose Frontal Fibrosing Alopecia.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.